This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Dialysis Patient Organizations Form Groundbreaking Partnership To Empower And Educate Patients

Work has started on a 90 day proof of concept for the Baseline Your Health Program, with the purpose of taking theoretical findings and providing hard data to support improved patient care. In the future DPC and the Shad Ireland Foundation will partner broadly on advocacy issues, joint messaging, Hill meetings and joint briefings. The Center and the Foundation will join forces to build national awareness of kidney disease and collaborate on patient-centric research efforts and jointly pursue grant funding opportunities.

About Dialysis Patient Citizens: DPC is America's largest patient-led organization representing dialysis patients. With a membership of more than 24,000 dialysis and pre-dialysis patients and their families, DPC's mission is to improve the quality of life of dialysis patients by engaging policy makers, providers and the public. Through patient education, empowerment and advocacy, DPC works to increase awareness about kidney disease and promote favorable public policy. More information:

About the DPC Education Center:  The DPC Education Center is dedicated to improving kidney patients' quality of life and reducing the occurrence of ESRD through education and by developing awareness of dialysis and kidney disease issues, improving the partnership between patients and caregivers, and developing favorable public policy solutions.  The Center is incorporated as a 501(c)(3) affiliate organization of Dialysis Patient Citizens. More information:  

About the Shad Ireland Foundation: The Shad Ireland Foundation is an international non-profit organization that is actively exploring ways to create strategic relationships that lead to the development of tools and resources, which positively impact individuals, families and communities affected by chronic kidney disease. More information:

PRESS CONTACT: Jessica Nagro O: 202-789-6931 C: 202-870-2141

SOURCE Dialysis Patient Citizens

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,118.78 -13.08 -0.08%
S&P 500 2,014.89 +15.91 0.80%
NASDAQ 4,815.5410 -23.1020 -0.48%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs